A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
The Gavin and Stacey star has come to the realisation that ‘nothing about my eating has anything to do with being hungry’ ...
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
The compounded GLP-1s that Noom and Hims & Hers are selling are roughly a fifth of the monthly cost of a drug like Ozempic.
Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to overdose.
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United ...
Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. | Novo Nordisk has earnt yet another dressing down ...
Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback